DXC Technology delists 1.750% Notes due 2026 from NYSE

DXC Technology Co has had its 1.750% Notes due 2026 removed from listing and registration on the New York Stock Exchange.

Accepted by SEC EDGAR 12/29/2025 - 09:00 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

DXC Technology Co has had its 1.750% Notes due 2026 removed from listing and registration on the New York Stock Exchange. The exchange filed a Form 25, stating it has followed its own rules under Section 12(b) of the Securities Exchange Act of 1934 to strike this class of notes from listing. The filing also notes that the issuer has complied with the exchange’s rules and applicable SEC requirements for voluntarily withdrawing this class of securities from listing and registration. This means these DXC notes will no longer trade on the NYSE, although the filing does not address any other trading venues or terms of the notes.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did DXC (DXC) disclose about its 1.750% Notes due 2026?

The company’s 1.750% Notes due 2026 have been removed from listing and registration on the New York Stock Exchange, as documented in a Form 25 filing.

Which DXC security is affected by this Form 25 filing?

The filing applies specifically to DXC Technology Co 1.750% Notes due 2026, which were previously listed on the New York Stock Exchange.

Who initiated the delisting of DXC’s 1.750% Notes due 2026?

The Form 25 is certified by New York Stock Exchange LLC, which states it has complied with its rules to strike the notes from listing and registration.

Did DXC comply with exchange and SEC rules for withdrawing these notes?

Yes. The filing states that the issuer has complied with the rules of the exchange and the requirements of 17 CFR 240.12d2-2(c) for voluntary withdrawal.

Will DXC’s 1.750% Notes due 2026 continue trading on the NYSE?

No. The Form 25 states that this class of notes is being struck from listing and registration on the New York Stock Exchange.

Does the Form 25 say anything about other markets for DXC’s notes?

The content provided only addresses removal from listing and registration on the New York Stock Exchange and does not discuss other trading venues.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-38033

Issuer:	DXC Technology Co
Exchange:	NEW YORK STOCK EXCHANGE LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	20408 Bashan DriveSuite 231
	Ashburn	VIRGINIA	20147
Telephone number:

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

1.750% Notes due 2026

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, NEW YORK STOCK EXCHANGE LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2025-12-29	By	Tyler Mastronardi		Analyst, Market Watch
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.